Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seqirus
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female aged 18 and older, inclusive, at the time of providing informed consent.
Females of child bearing potential (i.e., ovulating, pre-menopausal, not surgically sterile) must be abstinent or be willing to use a medically accepted contraceptive regimen for the duration of the study. Females of child bearing potential must return a negative urine pregnancy test result at enrolment and prior to each study vaccination.
You may not be if
Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to eggs, chicken protein, thimerosal, neomycin, polymyxin, or any components of the Study Vaccine.
Clareo Health | A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA
